nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCC2—Sulfasalazine—ankylosing spondylitis	0.134	0.163	CbGbCtD
Vinblastine—ABCB11—Dexamethasone—ankylosing spondylitis	0.127	0.155	CbGbCtD
Vinblastine—ABCC1—Methotrexate—ankylosing spondylitis	0.0725	0.0885	CbGbCtD
Vinblastine—ABCC2—Dexamethasone—ankylosing spondylitis	0.0668	0.0815	CbGbCtD
Vinblastine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0576	0.0702	CbGbCtD
Vinblastine—ABCC2—Methotrexate—ankylosing spondylitis	0.0537	0.0655	CbGbCtD
Vinblastine—ABCB1—Betamethasone—ankylosing spondylitis	0.0374	0.0457	CbGbCtD
Vinblastine—ABCB1—Prednisolone—ankylosing spondylitis	0.0369	0.0451	CbGbCtD
Vinblastine—ABCB1—Prednisone—ankylosing spondylitis	0.0349	0.0426	CbGbCtD
Vinblastine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0345	0.0421	CbGbCtD
Vinblastine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0261	0.0319	CbGbCtD
Vinblastine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0224	0.0274	CbGbCtD
Vinblastine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0221	0.027	CbGbCtD
Vinblastine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0218	0.0266	CbGbCtD
Vinblastine—CYP3A4—Prednisone—ankylosing spondylitis	0.0209	0.0255	CbGbCtD
Vinblastine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0205	0.025	CbGbCtD
Vinblastine—ABCB1—Methotrexate—ankylosing spondylitis	0.0175	0.0214	CbGbCtD
Vinblastine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.013	0.0159	CbGbCtD
Vinblastine—TUBB6—Orphan transporters—ANO6—ankylosing spondylitis	0.00337	0.0418	CbGpPWpGaD
Vinblastine—TUBB2B—Orphan transporters—ANO6—ankylosing spondylitis	0.00337	0.0418	CbGpPWpGaD
Vinblastine—TUBB3—Orphan transporters—ANO6—ankylosing spondylitis	0.00326	0.0404	CbGpPWpGaD
Vinblastine—TUBB2A—Orphan transporters—ANO6—ankylosing spondylitis	0.00315	0.0391	CbGpPWpGaD
Vinblastine—TUBB1—Orphan transporters—ANO6—ankylosing spondylitis	0.00308	0.0382	CbGpPWpGaD
Vinblastine—JUN—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.0029	0.036	CbGpPWpGaD
Vinblastine—TUBB4A—Orphan transporters—ANO6—ankylosing spondylitis	0.00277	0.0343	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.00257	0.0318	CbGpPWpGaD
Vinblastine—TUBB4B—Orphan transporters—ANO6—ankylosing spondylitis	0.00253	0.0314	CbGpPWpGaD
Vinblastine—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.00197	0.0217	CcSEcCtD
Vinblastine—TUBB8—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00183	0.0228	CbGpPWpGaD
Vinblastine—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.00182	0.02	CcSEcCtD
Vinblastine—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.00181	0.0199	CcSEcCtD
Vinblastine—Neuritis—Prednisolone—ankylosing spondylitis	0.00177	0.0194	CcSEcCtD
Vinblastine—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.00165	0.0181	CcSEcCtD
Vinblastine—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.00165	0.0181	CcSEcCtD
Vinblastine—Neuritis—Triamcinolone—ankylosing spondylitis	0.00163	0.0179	CcSEcCtD
Vinblastine—Neuritis—Methylprednisolone—ankylosing spondylitis	0.00162	0.0178	CcSEcCtD
Vinblastine—ABCC6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00149	0.0185	CbGpPWpGaD
Vinblastine—Neuritis—Dexamethasone—ankylosing spondylitis	0.00147	0.0162	CcSEcCtD
Vinblastine—Neuritis—Betamethasone—ankylosing spondylitis	0.00147	0.0162	CcSEcCtD
Vinblastine—Peptic ulcer—Prednisone—ankylosing spondylitis	0.00143	0.0158	CcSEcCtD
Vinblastine—JUN—TGF-beta Receptor Signaling—RUNX3—ankylosing spondylitis	0.00137	0.017	CbGpPWpGaD
Vinblastine—JUN—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.00137	0.017	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.00132	0.0164	CbGpPWpGaD
Vinblastine—Neuritis—Prednisone—ankylosing spondylitis	0.00128	0.0141	CcSEcCtD
Vinblastine—Extravasation—Betamethasone—ankylosing spondylitis	0.00126	0.0139	CcSEcCtD
Vinblastine—Extravasation—Dexamethasone—ankylosing spondylitis	0.00126	0.0139	CcSEcCtD
Vinblastine—TUBA1A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00115	0.0143	CbGpPWpGaD
Vinblastine—JUN—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00112	0.0138	CbGpPWpGaD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00106	0.0131	CbGpPWpGaD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.000993	0.0123	CbGpPWpGaD
Vinblastine—JUN—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000988	0.0123	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000963	0.105	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000963	0.105	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000948	0.104	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000948	0.104	CbGdCrCtD
Vinblastine—JUN—CD40/CD40L signaling—CD40LG—ankylosing spondylitis	0.000939	0.0116	CbGpPWpGaD
Vinblastine—TUBB2B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000928	0.0115	CbGpPWpGaD
Vinblastine—TUBB6—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000928	0.0115	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000926	0.101	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000926	0.101	CbGdCrCtD
Vinblastine—TUBB—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.00092	0.0114	CbGpPWpGaD
Vinblastine—Extravasation—Methotrexate—ankylosing spondylitis	0.000918	0.0101	CcSEcCtD
Vinblastine—TUBB3—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000896	0.0111	CbGpPWpGaD
Vinblastine—JUN—Dexamethasone—Prednisone—ankylosing spondylitis	0.000879	0.0961	CbGdCrCtD
Vinblastine—JUN—Betamethasone—Prednisone—ankylosing spondylitis	0.000879	0.0961	CbGdCrCtD
Vinblastine—TUBB2A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000868	0.0108	CbGpPWpGaD
Vinblastine—JUN—Betamethasone—Prednisolone—ankylosing spondylitis	0.000858	0.0938	CbGdCrCtD
Vinblastine—JUN—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000858	0.0938	CbGdCrCtD
Vinblastine—TUBB1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000849	0.0105	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.000835	0.0103	CbGpPWpGaD
Vinblastine—TUBB2B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000823	0.0102	CbGpPWpGaD
Vinblastine—TUBB6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000823	0.0102	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000809	0.01	CbGpPWpGaD
Vinblastine—TUBB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000795	0.00986	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000787	0.00975	CbGpPWpGaD
Vinblastine—TUBB2A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00077	0.00955	CbGpPWpGaD
Vinblastine—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000762	0.00945	CbGpPWpGaD
Vinblastine—TUBB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000753	0.00934	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000738	0.00915	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000731	0.00907	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000728	0.008	CcSEcCtD
Vinblastine—Neoplasm—Methotrexate—ankylosing spondylitis	0.000724	0.00796	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000723	0.00795	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000723	0.00795	CcSEcCtD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000722	0.00895	CbGpPWpGaD
Vinblastine—JUN—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000701	0.00869	CbGpPWpGaD
Vinblastine—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000697	0.00864	CbGpPWpGaD
Vinblastine—TUBB4A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000676	0.00838	CbGpPWpGaD
Vinblastine—JUN—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000673	0.00834	CbGpPWpGaD
Vinblastine—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000669	0.00736	CcSEcCtD
Vinblastine—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000668	0.00734	CcSEcCtD
Vinblastine—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000666	0.00732	CcSEcCtD
Vinblastine—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000665	0.00731	CcSEcCtD
Vinblastine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000665	0.00731	CcSEcCtD
Vinblastine—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000664	0.0073	CcSEcCtD
Vinblastine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000664	0.0073	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000664	0.00823	CbGpPWpGaD
Vinblastine—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000663	0.00728	CcSEcCtD
Vinblastine—JUN—IL6-mediated signaling events—CRP—ankylosing spondylitis	0.000638	0.00791	CbGpPWpGaD
Vinblastine—TUBB4B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000618	0.00767	CbGpPWpGaD
Vinblastine—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000612	0.00673	CcSEcCtD
Vinblastine—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000611	0.00672	CcSEcCtD
Vinblastine—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000609	0.0067	CcSEcCtD
Vinblastine—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000608	0.00668	CcSEcCtD
Vinblastine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000607	0.00667	CcSEcCtD
Vinblastine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000607	0.00667	CcSEcCtD
Vinblastine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000605	0.00665	CcSEcCtD
Vinblastine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000604	0.00664	CcSEcCtD
Vinblastine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000604	0.00664	CcSEcCtD
Vinblastine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000604	0.00664	CcSEcCtD
Vinblastine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000604	0.00664	CcSEcCtD
Vinblastine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000594	0.00653	CcSEcCtD
Vinblastine—JUN—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000588	0.00729	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000558	0.00692	CbGpPWpGaD
Vinblastine—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000556	0.00611	CcSEcCtD
Vinblastine—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000556	0.00611	CcSEcCtD
Vinblastine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000553	0.00608	CcSEcCtD
Vinblastine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000553	0.00608	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.000551	0.00684	CbGpPWpGaD
Vinblastine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000535	0.00588	CcSEcCtD
Vinblastine—Depression—Prednisone—ankylosing spondylitis	0.000535	0.00588	CcSEcCtD
Vinblastine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000529	0.00581	CcSEcCtD
Vinblastine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000526	0.00578	CcSEcCtD
Vinblastine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000526	0.00578	CcSEcCtD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000521	0.00646	CbGpPWpGaD
Vinblastine—Malaise—Prednisolone—ankylosing spondylitis	0.00052	0.00572	CcSEcCtD
Vinblastine—Vertigo—Prednisolone—ankylosing spondylitis	0.000518	0.0057	CcSEcCtD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000509	0.00632	CbGpPWpGaD
Vinblastine—Convulsion—Prednisolone—ankylosing spondylitis	0.0005	0.00549	CcSEcCtD
Vinblastine—Hypertension—Prednisolone—ankylosing spondylitis	0.000498	0.00547	CcSEcCtD
Vinblastine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000492	0.00541	CcSEcCtD
Vinblastine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000491	0.0054	CcSEcCtD
Vinblastine—JUN—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	0.000491	0.00608	CbGpPWpGaD
Vinblastine—Alopecia—Betamethasone—ankylosing spondylitis	0.000489	0.00537	CcSEcCtD
Vinblastine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000489	0.00537	CcSEcCtD
Vinblastine—JUN—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.000486	0.00603	CbGpPWpGaD
Vinblastine—Discomfort—Prednisolone—ankylosing spondylitis	0.000485	0.00533	CcSEcCtD
Vinblastine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000484	0.00532	CcSEcCtD
Vinblastine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000481	0.00529	CcSEcCtD
Vinblastine—Malaise—Triamcinolone—ankylosing spondylitis	0.000478	0.00526	CcSEcCtD
Vinblastine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000477	0.00525	CcSEcCtD
Vinblastine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000477	0.00525	CcSEcCtD
Vinblastine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000477	0.00524	CcSEcCtD
Vinblastine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000475	0.00523	CcSEcCtD
Vinblastine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00046	0.00505	CcSEcCtD
Vinblastine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000459	0.00504	CcSEcCtD
Vinblastine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000458	0.00503	CcSEcCtD
Vinblastine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000457	0.00502	CcSEcCtD
Vinblastine—JUN—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000454	0.00562	CbGpPWpGaD
Vinblastine—Depression—Methotrexate—ankylosing spondylitis	0.000447	0.00491	CcSEcCtD
Vinblastine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000447	0.00491	CcSEcCtD
Vinblastine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000447	0.00491	CcSEcCtD
Vinblastine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000446	0.0049	CcSEcCtD
Vinblastine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000445	0.00489	CcSEcCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000436	0.0054	CbGpPWpGaD
Vinblastine—Malaise—Dexamethasone—ankylosing spondylitis	0.000434	0.00477	CcSEcCtD
Vinblastine—Malaise—Betamethasone—ankylosing spondylitis	0.000434	0.00477	CcSEcCtD
Vinblastine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000432	0.00475	CcSEcCtD
Vinblastine—Vertigo—Betamethasone—ankylosing spondylitis	0.000432	0.00475	CcSEcCtD
Vinblastine—Alopecia—Prednisone—ankylosing spondylitis	0.000425	0.00468	CcSEcCtD
Vinblastine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000423	0.00465	CcSEcCtD
Vinblastine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000418	0.0046	CcSEcCtD
Vinblastine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000417	0.00458	CcSEcCtD
Vinblastine—Convulsion—Betamethasone—ankylosing spondylitis	0.000417	0.00458	CcSEcCtD
Vinblastine—TUBA1A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000416	0.00515	CbGpPWpGaD
Vinblastine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000416	0.00457	CcSEcCtD
Vinblastine—Hypertension—Betamethasone—ankylosing spondylitis	0.000416	0.00457	CcSEcCtD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000406	0.00503	CbGpPWpGaD
Vinblastine—Discomfort—Betamethasone—ankylosing spondylitis	0.000405	0.00445	CcSEcCtD
Vinblastine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000405	0.00445	CcSEcCtD
Vinblastine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000404	0.00445	CcSEcCtD
Vinblastine—Pain—Prednisolone—ankylosing spondylitis	0.000403	0.00443	CcSEcCtD
Vinblastine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000402	0.00442	CcSEcCtD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL1A—ankylosing spondylitis	0.000401	0.00497	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000401	0.00497	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0004	0.00495	CbGpPWpGaD
Vinblastine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000399	0.00439	CcSEcCtD
Vinblastine—ABCC1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000395	0.0049	CbGpPWpGaD
Vinblastine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000389	0.00428	CcSEcCtD
Vinblastine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000389	0.00427	CcSEcCtD
Vinblastine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000388	0.00426	CcSEcCtD
Vinblastine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000388	0.00426	CcSEcCtD
Vinblastine—Anaemia—Prednisone—ankylosing spondylitis	0.000387	0.00426	CcSEcCtD
Vinblastine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000385	0.00423	CcSEcCtD
Vinblastine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000385	0.00423	CcSEcCtD
Vinblastine—Malaise—Prednisone—ankylosing spondylitis	0.000378	0.00416	CcSEcCtD
Vinblastine—Vertigo—Prednisone—ankylosing spondylitis	0.000377	0.00414	CcSEcCtD
Vinblastine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000374	0.00412	CcSEcCtD
Vinblastine—Anorexia—Betamethasone—ankylosing spondylitis	0.000374	0.00412	CcSEcCtD
Vinblastine—Pain—Triamcinolone—ankylosing spondylitis	0.00037	0.00407	CcSEcCtD
Vinblastine—Convulsion—Prednisone—ankylosing spondylitis	0.000363	0.00399	CcSEcCtD
Vinblastine—Hypertension—Prednisone—ankylosing spondylitis	0.000362	0.00398	CcSEcCtD
Vinblastine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000357	0.00392	CcSEcCtD
Vinblastine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000356	0.00391	CcSEcCtD
Vinblastine—Alopecia—Methotrexate—ankylosing spondylitis	0.000356	0.00391	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000353	0.00388	CcSEcCtD
Vinblastine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000353	0.00388	CcSEcCtD
Vinblastine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000353	0.00388	CcSEcCtD
Vinblastine—Discomfort—Prednisone—ankylosing spondylitis	0.000353	0.00388	CcSEcCtD
Vinblastine—JUN—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.000351	0.00435	CbGpPWpGaD
Vinblastine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000347	0.00381	CcSEcCtD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000344	0.00426	CbGpPWpGaD
Vinblastine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000341	0.00375	CcSEcCtD
Vinblastine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000341	0.00375	CcSEcCtD
Vinblastine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000341	0.00375	CcSEcCtD
Vinblastine—JUN—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000337	0.00418	CbGpPWpGaD
Vinblastine—Pain—Dexamethasone—ankylosing spondylitis	0.000336	0.00369	CcSEcCtD
Vinblastine—Pain—Betamethasone—ankylosing spondylitis	0.000336	0.00369	CcSEcCtD
Vinblastine—TUBB2B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000334	0.00414	CbGpPWpGaD
Vinblastine—TUBB6—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000334	0.00414	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000329	0.00408	CbGpPWpGaD
Vinblastine—Anorexia—Prednisone—ankylosing spondylitis	0.000326	0.00358	CcSEcCtD
Vinblastine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000325	0.00357	CcSEcCtD
Vinblastine—Anaemia—Methotrexate—ankylosing spondylitis	0.000324	0.00356	CcSEcCtD
Vinblastine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000324	0.00356	CcSEcCtD
Vinblastine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000324	0.00356	CcSEcCtD
Vinblastine—TUBB3—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000323	0.004	CbGpPWpGaD
Vinblastine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000321	0.00353	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000321	0.00353	CcSEcCtD
Vinblastine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000319	0.00351	CcSEcCtD
Vinblastine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000318	0.0035	CcSEcCtD
Vinblastine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000316	0.00392	CbGpPWpGaD
Vinblastine—Malaise—Methotrexate—ankylosing spondylitis	0.000316	0.00347	CcSEcCtD
Vinblastine—JUN—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000316	0.00392	CbGpPWpGaD
Vinblastine—JUN—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.000316	0.00392	CbGpPWpGaD
Vinblastine—Vertigo—Methotrexate—ankylosing spondylitis	0.000315	0.00346	CcSEcCtD
Vinblastine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000314	0.00345	CcSEcCtD
Vinblastine—TUBB2A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000313	0.00388	CbGpPWpGaD
Vinblastine—Dizziness—Prednisolone—ankylosing spondylitis	0.000311	0.00342	CcSEcCtD
Vinblastine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000311	0.00341	CcSEcCtD
Vinblastine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000311	0.00341	CcSEcCtD
Vinblastine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000311	0.00341	CcSEcCtD
Vinblastine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00031	0.00341	CcSEcCtD
Vinblastine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000307	0.00338	CcSEcCtD
Vinblastine—TUBB1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000306	0.00379	CbGpPWpGaD
Vinblastine—Convulsion—Methotrexate—ankylosing spondylitis	0.000303	0.00334	CcSEcCtD
Vinblastine—JUN—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000303	0.00376	CbGpPWpGaD
Vinblastine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000297	0.00327	CcSEcCtD
Vinblastine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000296	0.00325	CcSEcCtD
Vinblastine—Headache—Prednisolone—ankylosing spondylitis	0.000295	0.00324	CcSEcCtD
Vinblastine—Discomfort—Methotrexate—ankylosing spondylitis	0.000295	0.00324	CcSEcCtD
Vinblastine—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000294	0.00364	CbGpPWpGaD
Vinblastine—Constipation—Prednisone—ankylosing spondylitis	0.000293	0.00322	CcSEcCtD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000292	0.00362	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00029	0.0036	CbGpPWpGaD
Vinblastine—JUN—Immune System—KIR3DL1—ankylosing spondylitis	0.00029	0.00359	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000289	0.00359	CbGpPWpGaD
Vinblastine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000286	0.00315	CcSEcCtD
Vinblastine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000286	0.00314	CcSEcCtD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000285	0.00353	CbGpPWpGaD
Vinblastine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000282	0.0031	CcSEcCtD
Vinblastine—Asthenia—Betamethasone—ankylosing spondylitis	0.000282	0.0031	CcSEcCtD
Vinblastine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000282	0.0031	CcSEcCtD
Vinblastine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Vinblastine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Vinblastine—Nausea—Prednisolone—ankylosing spondylitis	0.00028	0.00307	CcSEcCtD
Vinblastine—JUN—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000275	0.00341	CbGpPWpGaD
Vinblastine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000275	0.00303	CcSEcCtD
Vinblastine—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000275	0.00341	CbGpPWpGaD
Vinblastine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000275	0.00302	CcSEcCtD
Vinblastine—TUBB4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000274	0.0034	CbGpPWpGaD
Vinblastine—Anorexia—Methotrexate—ankylosing spondylitis	0.000273	0.003	CcSEcCtD
Vinblastine—Headache—Triamcinolone—ankylosing spondylitis	0.000271	0.00298	CcSEcCtD
Vinblastine—Headache—Methylprednisolone—ankylosing spondylitis	0.000271	0.00297	CcSEcCtD
Vinblastine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00027	0.00297	CcSEcCtD
Vinblastine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000269	0.00333	CbGpPWpGaD
Vinblastine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000269	0.00295	CcSEcCtD
Vinblastine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000269	0.00295	CcSEcCtD
Vinblastine—JUN—Innate Immune System—CARD9—ankylosing spondylitis	0.000261	0.00324	CbGpPWpGaD
Vinblastine—Dizziness—Betamethasone—ankylosing spondylitis	0.00026	0.00286	CcSEcCtD
Vinblastine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00026	0.00286	CcSEcCtD
Vinblastine—JUN—TGF-beta Receptor Signaling—TNF—ankylosing spondylitis	0.000258	0.0032	CbGpPWpGaD
Vinblastine—Nausea—Triamcinolone—ankylosing spondylitis	0.000257	0.00283	CcSEcCtD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000257	0.00318	CbGpPWpGaD
Vinblastine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000257	0.00282	CcSEcCtD
Vinblastine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000257	0.00282	CcSEcCtD
Vinblastine—JUN—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000254	0.00315	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL1A—ankylosing spondylitis	0.000254	0.00315	CbGpPWpGaD
Vinblastine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000252	0.00277	CcSEcCtD
Vinblastine—TUBB4B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000251	0.00311	CbGpPWpGaD
Vinblastine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00025	0.00275	CcSEcCtD
Vinblastine—Vomiting—Betamethasone—ankylosing spondylitis	0.00025	0.00275	CcSEcCtD
Vinblastine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000249	0.00273	CcSEcCtD
Vinblastine—Headache—Betamethasone—ankylosing spondylitis	0.000246	0.00271	CcSEcCtD
Vinblastine—Headache—Dexamethasone—ankylosing spondylitis	0.000246	0.00271	CcSEcCtD
Vinblastine—Asthenia—Prednisone—ankylosing spondylitis	0.000245	0.0027	CcSEcCtD
Vinblastine—Pain—Methotrexate—ankylosing spondylitis	0.000244	0.00269	CcSEcCtD
Vinblastine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000236	0.00259	CcSEcCtD
Vinblastine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000234	0.00257	CcSEcCtD
Vinblastine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000234	0.00257	CcSEcCtD
Vinblastine—Nausea—Dexamethasone—ankylosing spondylitis	0.000233	0.00256	CcSEcCtD
Vinblastine—Nausea—Betamethasone—ankylosing spondylitis	0.000233	0.00256	CcSEcCtD
Vinblastine—Dizziness—Prednisone—ankylosing spondylitis	0.000226	0.00249	CcSEcCtD
Vinblastine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000226	0.00248	CcSEcCtD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.00022	0.00273	CbGpPWpGaD
Vinblastine—Vomiting—Prednisone—ankylosing spondylitis	0.000217	0.00239	CcSEcCtD
Vinblastine—Headache—Prednisone—ankylosing spondylitis	0.000214	0.00236	CcSEcCtD
Vinblastine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000211	0.00232	CcSEcCtD
Vinblastine—Asthenia—Methotrexate—ankylosing spondylitis	0.000205	0.00225	CcSEcCtD
Vinblastine—Nausea—Prednisone—ankylosing spondylitis	0.000203	0.00223	CcSEcCtD
Vinblastine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000198	0.00245	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000197	0.00244	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000197	0.00244	CbGpPWpGaD
Vinblastine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000196	0.00215	CcSEcCtD
Vinblastine—JUN—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000192	0.00238	CbGpPWpGaD
Vinblastine—Dizziness—Methotrexate—ankylosing spondylitis	0.000189	0.00208	CcSEcCtD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000188	0.00233	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000187	0.00232	CbGpPWpGaD
Vinblastine—Vomiting—Methotrexate—ankylosing spondylitis	0.000182	0.002	CcSEcCtD
Vinblastine—JUN—Apoptosis—TNF—ankylosing spondylitis	0.000181	0.00225	CbGpPWpGaD
Vinblastine—Headache—Methotrexate—ankylosing spondylitis	0.000179	0.00197	CcSEcCtD
Vinblastine—JUN—Immune System—IL1R2—ankylosing spondylitis	0.000176	0.00218	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000173	0.00215	CbGpPWpGaD
Vinblastine—Nausea—Methotrexate—ankylosing spondylitis	0.00017	0.00187	CcSEcCtD
Vinblastine—JUN—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000169	0.00209	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ANTXR2—ankylosing spondylitis	0.000167	0.00208	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERAP1—ankylosing spondylitis	0.000166	0.00206	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-C—ankylosing spondylitis	0.000164	0.00203	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000155	0.00193	CbGpPWpGaD
Vinblastine—JUN—Immune System—CARD9—ankylosing spondylitis	0.000152	0.00189	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—TNF—ankylosing spondylitis	0.000134	0.00166	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000121	0.0015	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000111	0.00137	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—B3GNT2—ankylosing spondylitis	0.00011	0.00136	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000104	0.00129	CbGpPWpGaD
Vinblastine—ABCC1—Disease—B3GNT2—ankylosing spondylitis	9.87e-05	0.00122	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HLA-B—ankylosing spondylitis	9.7e-05	0.0012	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-C—ankylosing spondylitis	9.56e-05	0.00119	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	9.4e-05	0.00117	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—CRP—ankylosing spondylitis	8.58e-05	0.00106	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1RN—ankylosing spondylitis	8.3e-05	0.00103	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—B3GNT2—ankylosing spondylitis	8.26e-05	0.00102	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—TLR4—ankylosing spondylitis	8.22e-05	0.00102	CbGpPWpGaD
Vinblastine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	7.48e-05	0.000928	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD79A—ankylosing spondylitis	7.29e-05	0.000904	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	7.19e-05	0.000892	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1A—ankylosing spondylitis	5.98e-05	0.000741	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD40LG—ankylosing spondylitis	5.94e-05	0.000737	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTGER4—ankylosing spondylitis	5.74e-05	0.000712	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-B—ankylosing spondylitis	5.65e-05	0.000701	CbGpPWpGaD
Vinblastine—JUN—Immune System—HLA-A—ankylosing spondylitis	5.24e-05	0.000649	CbGpPWpGaD
Vinblastine—JUN—Immune System—CRP—ankylosing spondylitis	5e-05	0.000619	CbGpPWpGaD
Vinblastine—JUN—Immune System—TLR4—ankylosing spondylitis	4.79e-05	0.000594	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP3—ankylosing spondylitis	4.09e-05	0.000507	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HLA-A—ankylosing spondylitis	3.99e-05	0.000495	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.93e-05	0.000487	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	3.7e-05	0.000459	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.69e-05	0.000458	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.42e-05	0.0003	CbGpPWpGaD
